Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 16, 569-574, August 1, 1956]
© 1956 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schultz, J.
Right arrow Articles by Gruenstein, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schultz, J.
Right arrow Articles by Gruenstein, M.

The Chemistry of Experimental Chloroma

III. Activity and Activation of VPO in Cellular Particulates*

Julius Schultz, Anne Turtle, Harry Shay and Margot Gruenstein

( Samuel S. Fels Research Institute, Temple University School of Medicine, Philadelphia, Pa.)

A supernatant which showed that the activation of VPO activity was free of mitochondria (to succinoxidase activity) contained a hemeprotein whose reduced-difference spectrum had a peak at 430 and a CO-reduced peak at 420, fluoresced yellow under ultraviolet light, and was not sedimented at 25,000 g after 1 hour. The fact that hemoglobin did not affect the activity of VPO does not eliminate the 430 peak as being due to hemoglobin. However, the 430 compound was associated with factors containing the activator. Part of the unusually high peroxidase activity may be accounted for by the presence of this activator rather than by the verdoperoxidase per se. If due to the former, one would expect to isolate a great deal less than would be expected from the activity.

* This investigation was supported by a research grant C-1966 (C2) from the National Cancer Institute of the National Institutes of Health, Public Health Service.

Received 12/19/55.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1956 by the American Association for Cancer Research.